Abstract
Several genes have been demonstrated to affect disease severity in CF. Furthermore, it is likely that gene-gene and gene-environment interactions can explain a substantial portion of the variation of lung disease. Ongoing genome-wide studies are likely to identify novel genetic modifiers. Continued exploration of the role of genetic and nongenetic modifiers of CF is likely to yield new options for combating this debilitating disease.
Original language | English (US) |
---|---|
Pages (from-to) | 559-566 |
Number of pages | 8 |
Journal | Current opinion in pulmonary medicine |
Volume | 14 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2008 |
Keywords
- Cystic fibrosis
- Genome-wide
- Interaction
- Modifier gene
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine